astragaloside a has been researched along with oleic acid in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (oleic acid) | Trials (oleic acid) | Recent Studies (post-2010) (oleic acid) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 8,768 | 248 | 3,051 |
| Protein | Taxonomy | astragaloside a (IC50) | oleic acid (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, B; Tang, WJ; Wang, LL; Zhou, X | 1 |
1 other study(ies) available for astragaloside a and oleic acid
| Article | Year |
|---|---|
Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells.
Topics: Cell Survival; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Insulin Resistance; Oleic Acid; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Saponins; Triglycerides; Triterpenes | 2021 |